Skip to main content
Clinical Trials/NCT03260907
NCT03260907
Unknown
Not Applicable

Efficacy and Safety of Electroacupuncture and Acupuncture in Postmenopausal Women With Overactive Bladder ; A Multicenter, Randomized, Controlled, Parallel Clinical Trial

DongGuk University1 site in 1 country98 target enrollmentMarch 2, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Overactive Bladder
Sponsor
DongGuk University
Enrollment
98
Locations
1
Primary Endpoint
3-day bladder diary change
Last Updated
8 years ago

Overview

Brief Summary

The purpose of this study is to verify the efficacy and safety of electroacupuncture treatment of postmenopausal women with overactive bladder (OAB).

Detailed Description

The investigators targeted the patients of menopausal women with OAB. After treatment in 2 groups - electroacupuncture treatment and acupuncture treatment - the investigators will compare the improvement of the urinary symptoms and the quality of life, and further the best treatment method. In addition, the investigators are going to evaluate the safety of abnormal reaction during the treatment.

Registry
clinicaltrials.gov
Start Date
March 2, 2018
End Date
December 31, 2018
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jung Seunghyun

Principal Investigator

DongGuk University

Eligibility Criteria

Inclusion Criteria

  • Women over 40 years of age without the possibility of pregnancy
  • Have a history of amenorrhea for at least 1 year and have no previous history of hormone replacement therapy for the last 6 months
  • With symptoms of urinary frequency and urgency lasting more than three months
  • Who fit the diagnostic criteria for OAB, with a total score more than three points in Korean version overactive bladder symptom score (OABSS)
  • Who have average urinary frequency of more than eight times per day and urgency which is defined as urgency rating scale (URS) on bladder diary is more than two points and/or UUI on 3-day bladder diary during one week screening period
  • Who agree to this clinical study after sufficient explanation

Exclusion Criteria

  • Diag¬nosed with UTI by urine examination
  • With stress urinary incontinence without symptoms of OAB
  • With suspected of having voiding dys¬function induced by neurological damage
  • With a medical history of cystocele, uterine pro¬lapse or similar
  • With a medical history of obstructive uropathy such as urinary stones and urinary tumors
  • With a surgical history of urethra or bladder
  • With a medical history of malignant tumors of urinary tract
  • With a medical history of neurologic disease or psychi¬atric illness
  • Have an artificial cardiac pacemaker or implantable cardioverter defibrillator in the chest
  • Have experienced a hypersensitivity reaction after an acupuncture treatment, or show any other contraindications;

Outcomes

Primary Outcomes

3-day bladder diary change

Time Frame: at baseline, after 6 weeks of treatment (the end of the treatment period), after 10 weeks of treatment(follow up evaluation)

The daytime micturitions per 24 hr, nocturnal micturitions per 24 hr, total count of urgency (sum of urgency epi¬sodes defined as URS ≥ 3 for three days), total urgency score (sum of urgency score for three days), and total count of UUI (sum of UUI episodes for three days) is checked.

Secondary Outcomes

  • The King's Health Questionnaire (KHQ)(at baseline, after 6 weeks of treatment (the end of the treatment period), after 10 weeks of treatment(follow up evaluation))
  • The overactive bladder symptom score (OABSS) change(at baseline, after 6 weeks of treatment (the end of the treatment period), after 10 weeks of treatment(follow up evaluation))
  • Adverse events (AEs)(at baseline, every treatment(12 sessions in 6 weeks, including after 6 weeks of treatment (the end of the treatment period), after 10 weeks of treatment(follow up evaluation))

Study Sites (1)

Loading locations...

Similar Trials